Research Article
Open Access
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
Elena Azzolini, View ORCID ProfileChiara Pozzi, Luca Germagnoli, Bianca Oresta, Nicola Carriglio, Mariella Calleri, Carlo Selmi, View ORCID ProfileMaria De Santis, Silvia Finazzi, Carmelo Carlo-Stella, Alexia Bertuzzi, Francesca Motta, Angela Ceribelli, Alberto Mantovani, Fabrizio Bonelli, View ORCID ProfileMaria Rescigno Correspondence email
Elena Azzolini
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Conceptualization, Project administration
Chiara Pozzi
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Formal analysis, Project administration, Writing—original draft, review, and editing
Luca Germagnoli
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Formal analysis, Methodology
Bianca Oresta
3DiaSorin S.p.A., Saluggia VC, Italy
Roles: Data curation, Project administration
Nicola Carriglio
3DiaSorin S.p.A., Saluggia VC, Italy
Roles: Data curation, Project administration
Mariella Calleri
3DiaSorin S.p.A., Saluggia VC, Italy
Roles: Conceptualization, Resources, Project administration
Carlo Selmi
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Supervision, Writing—review and editing
Maria De Santis
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Silvia Finazzi
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Carmelo Carlo-Stella
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Alexia Bertuzzi
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Francesca Motta
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Angela Ceribelli
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Data curation, Investigation, Writing—review and editing
Alberto Mantovani
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
4William Harvey Research Institute, Queen Mary University of London, London, UK
Roles: Conceptualization, Supervision, Funding acquisition, Writing—review and editing
Fabrizio Bonelli
3DiaSorin S.p.A., Saluggia VC, Italy
Roles: Conceptualization, Resources, Supervision, Funding acquisition, Project administration
Maria Rescigno
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy
2Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy
Roles: Conceptualization, Supervision, Funding acquisition, Writing—original draft, review, and editing
Published 15 February 2022. DOI: 10.26508/lsa.202201381
COVID-19 vaccine booster in immunocompromised patients
Elena Azzolini, Chiara Pozzi, Luca Germagnoli, Bianca Oresta, Nicola Carriglio, Mariella Calleri, Carlo Selmi, Maria De Santis, Silvia Finazzi, Carmelo Carlo-Stella, Alexia Bertuzzi, Francesca Motta, Angela Ceribelli, Alberto Mantovani, Fabrizio Bonelli, Maria Rescigno
Life Science Alliance Feb 2022, 5 (6) e202201381; DOI: 10.26508/lsa.202201381
COVID-19 vaccine booster in immunocompromised patients
Elena Azzolini, Chiara Pozzi, Luca Germagnoli, Bianca Oresta, Nicola Carriglio, Mariella Calleri, Carlo Selmi, Maria De Santis, Silvia Finazzi, Carmelo Carlo-Stella, Alexia Bertuzzi, Francesca Motta, Angela Ceribelli, Alberto Mantovani, Fabrizio Bonelli, Maria Rescigno
Life Science Alliance Feb 2022, 5 (6) e202201381; DOI: 10.26508/lsa.202201381
In this Issue
Volume 5, No. 6
June 2022
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19
- B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab
- Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
- SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients